Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as leuprolide, goserelin, flutamide, or bicalutamide, may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving these drugs together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well androgen suppression with either leuprolide or goserelin and either flutamide or bicalutamide together with radiation therapy works in treating patients with prostate cancer.
Key facts
- Study ID
- NCT00006359
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 63
- Starts
- 2000-09-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2016-07-18
Who can join
Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Beebe Medical Center — Lewes, Delaware, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- St. Francis Hospital — Wilmington, Delaware, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando — Orlando, Florida, United States
- Union Hospital Cancer Center at Union Hospital — Elkton MD, Maryland, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Hudner Oncology Center at Saint Anne's Hospital — Fall River, Massachusetts, United States
- UMASS Memorial Cancer Center - University Campus — Worcester, Massachusetts, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia — Columbia, Missouri, United States
- CCOP - Kansas City — Kansas City, Missouri, United States
- Missouri Baptist Cancer Center — St Louis, Missouri, United States
- Arch Medical Services, Incoroporated at Center for Cancer Care Research — St Louis, Missouri, United States
- Washoe Cancer Services at Washoe Medical Center - Reno — Reno, Nevada, United States
- Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees — Camden, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. — Syracuse, New York, United States
- SUNY Upstate Medical University Hospital — Syracuse, New York, United States
- Veterans Affairs Medical Center - Syracuse — Syracuse, New York, United States
- Community General Hospital of Greater Syracuse — Syracuse, New York, United States
- Presbyterian Cancer Center at Presbyterian Hospital — Charlotte, North Carolina, United States
- Wayne Memorial Hospital, Incorporated — Goldsboro, North Carolina, United States
- Zimmer Cancer Center at New Hanover Regional Medical Center — Wilmington, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.